APA (7th ed.) Citation

Kunz, P., Sähr, H., Lehner, B., Fischer, C., Seebach, E., & Fellenberg, J. (2016). Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma. BMC cancer, 16, . https://doi.org/10.1186/s12885-016-2266-5

Chicago Style (17th ed.) Citation

Kunz, Pierre, Heiner Sähr, Burkhard Lehner, Christian Fischer, Elisabeth Seebach, and Jörg Fellenberg. "Elevated Ratio of MMP2/MMP9 Activity Is Associated with Poor Response to Chemotherapy in Osteosarcoma." BMC Cancer 16 (2016). https://doi.org/10.1186/s12885-016-2266-5.

MLA (9th ed.) Citation

Kunz, Pierre, et al. "Elevated Ratio of MMP2/MMP9 Activity Is Associated with Poor Response to Chemotherapy in Osteosarcoma." BMC Cancer, vol. 16, 2016, https://doi.org/10.1186/s12885-016-2266-5.